Previous Article | Next Article ![]()
Journal of Virology, February 2007, p. 1506-1510, Vol. 81, No. 3
0022-538X/07/$08.00+0 doi:10.1128/JVI.01522-06

Kathryn S. Jones,2,
Ivonne Lisinski,3,
Kazunori Fugo,1
Karen Yao,1
Samuel W. Cushman,3
Francis W. Ruscetti,4 and
Steven Jacobson1,
*
Viral Immunology Section, Neuroimmunology Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland 20892,1 Basic Research Program, SAIC-Frederick, Frederick, Maryland 21702,2 Experimental Diabetes, Metabolism, and Nutrition Section, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland 20892,3 Laboratory of Experimental Immunology, Center for Cancer Research, National Cancer Institute-Frederick, Frederick, Maryland 217024
Received 17 July 2006/ Accepted 5 November 2006
GLUT1 has recently been suggested to be a binding receptor for human T-cell leukemia virus type 1 (HTLV-1). We used a novel, short-term assay to define the role of GLUT1 in cell-to-cell transmission. Although increasing cell surface levels of GLUT1 enhanced HTLV-I transfer, efficient virus spread correlated largely with heparan sulfate proteoglycan (HSPG) expression on target cells. Moreover, since activated CD4+ T cells and cord blood lymphocytes that are susceptible to HTLV-1 infection expressed undetectable levels of surface GLUT1, these results indicate that GLUT1 and HSPGs are important for efficient cell-to-cell transmission of HTLV-1 but raise concerns on the role of GLUT1 as the HTLV-1 primary binding receptor.
Published ahead of print on 15 November 2006.
N.T., K.S.J., I.L., and S.J. have contributed equally to this report.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»